WCN26-3172 The Use of Low-Level Laser Therapy in Rats with Diabetic Kidney Disease

Read full text Summarise with VIRAT
Authors: Jessica Paola Garcia Villalba, Eloiza Oliveira Silva, Carla Djamila de Pina Victoria, Juliana Veloso Silva, Mikelly Gomes Alves, Maikol Lucas de Camargo Gonçalves, María de Fátima Fernandes Vattimo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Every nine seconds, one person dies as a result of complications from diabetes mellitus (DM), totalling approximately 3.4 million deaths in 2024. These figures reflect not only the global magnitude of this chronic disease but also the devastating impact of its complications, among which diabetic kidney disease (DKD) stands out as one of the most severe and silent microangiopathic manifestations of DM. Photobiomodulation (PBM), characterized as a method of low-intensity light to modulate biological processes, has emerged as a promising intervention.

Fields of Study & Subjects

Laser Applications in Dentistry and Medicine Photodynamic Therapy Research Studies Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104436–104436
Publication date
25 March 2026
Language
EN